Renew Intensive Skin Therapy Targeted Eczema Treatment
NDC 54473-410, Colloidal Oatmeal, cream, from Melaleuca Inc..
- Product NDC
- 54473-410
- Status
- Listed
- Labeler
- Melaleuca Inc.
- Dosage form
- CREAM
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- 505G(a)(3)
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/54473-410 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OATMEAL.5 g/50mL
Pharmacologic classes
Allergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Grain Proteins [EXT]; Increased Histamine Release [PE]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Plant Proteins [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 54473-410-01 | 54473041001 | 50 mL in 1 TUBE, WITH APPLICATOR (54473-410-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 54473-410 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/54473-410 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 54473-410. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.